What happens now with the estrogen-alone study?
A. Participants were asked on March 1, 2004, to stop their study medication and are being told whether they took the active drug or the placebo. WHI also gave this information to the women’s personal health care provider, if desired. Participants were asked to continue in the follow-up phase of the study, which is due to last until 2007. During the follow-up phase, the women will continue to undergo tests to monitor their health, including annual mammograms.
